Usefulness of Cytokeratin-18M65 in Diagnosing Non-Alcoholic Steatohepatitis in Japanese Population

Yutaka Hasegawa; Soo Ryang Kim; Takashi Hatae; Mitsuhiro Ohta; Aya Fujinami; Kayo Sugimoto; Ke Ih Kim; Susumu Imoto; Madoka Tohyama; Soo Ki Kim; Yoshihiro Ikura; Masatoshi Kudo

doi:10.1159/000439076

Back

Usefulness of Cytokeratin-18M65 in Diagnosing Non-Alcoholic Steatohepatitis in Japanese Population

Article 2015 en

Abstract

1 min read

Serum CK-18M65 distinguished NASH from SS, but could not assess the severity of steatosis in NAFLD patients or the grade of fibrosis in NASH patients in Japanese population.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Fructose and Non-Alcoholic Steatohepatitis

Elke Roeb, Ralf Weiskirchen

Article2020

L-Selectin/CD62L Is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men

Hannah K. Drescher, Angela Schippers, Stefanie Rosenhain, Felix Gremse, Laura Bongiovanni, Alain de Bruin, Sreepradha Eswaran, Suchira Gallage, Dominik Pfister, Marta Szydlowska, Mathias Heikenwälder, Sabine Weiskirchen, Norbert Wagner, Christian Trautwein, Ralf Weiskirchen, Daniela C. Kroy

Article2017

Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients

Natsuko Kobayashi, Takashi Kumada, Hidenori Toyoda, Toshifumi Tada, Takanori Ito, Masayoshi Kage, Takeshi Okanoue, Masatoshi Kudo

Article2015

Abstract PL03-03: ER stress and TNF signaling control the progression from simple steatosis to non-alcoholic steatohepatitis (NASH)

Michael Karin

Article2021

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention

Frank Tacke, Ralf Weiskirchen